Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 12INDUSTRY 2NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Breast Neoplasms 10Lung Neoplasms 9Colorectal Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Rectal Neoplasms 7Adenocarcinoma of Lung 7Colonic Neoplasms 5Adenocarcinoma, Bronchiolo-Alveolar 4Glioblastoma 3Brain Neoplasms 3Ovarian Neoplasms 2Neoplasm Metastasis 2Inflammatory Breast Neoplasms 2Gliosarcoma 2Carcinoma 2Breast Neoplasms, Male 2Unspecified Adult Solid Tumor, Protocol Specific 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Oligodendroglioma 1Non Small Cell Lung Cancer Metastatic 1Meningioma 1Medulloblastoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Glioma 1Fallopian Tube Neoplasms 1Erythema Multiforme 1Ependymoma 1Cognition Disorders 1

Interventions

Radiotherapy 38Temozolomide 27Vincristine 15Chemotherapy, Adjuvant 11Carboplatin 11Filgrastim 10Granulocyte Colony-Stimulating Factor 9Etoposide 9Cyclophosphamide 9Lomustine 8Carmustine 7Cisplatin 6Peripheral Blood Stem Cell Transplantation 5etoposide phosphate 4Thiotepa 4Radiotherapy, Intensity-Modulated 4Radiotherapy, Conformal 4Procarbazine 4Neoadjuvant Therapy 4Irinotecan 4Immunohistochemistry 4Gene Expression Profiling 4Topotecan 3Radiosurgery 3Radiation 3lonafarnib 2Psychiatric Rehabilitation 2Microarray Analysis 2Methotrexate 2Mesna 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Central Nervous System Neoplasms × Bevacizumab × Clear all
NCT01164189 2019-02-28

TAVAREC

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
155 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡